
MindMed Study at Psych Congress 2025 Finds High Suicidal Ideation in Adults with GAD
MindMed Study Highlights Alarmingly High Rates of Suicidal Ideation in Adults with Generalized Anxiety Disorder Researchers from Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a late-stage clinical biopharmaceutical company pioneering innovative therapies for brain health disorders, have unveiled concerning findings from…












